Laron syndrome: typical and atypical forms (Q41148777)

27 September 2017

1 reference

title

Laron syndrome: typical and atypical forms (English)

1 reference

27 September 2017

1 reference

2

Savage MO

1 reference

27 September 2017

Woods KA

1

1 reference

27 September 2017

publication date

1 July 1996

1 reference

Bailliere's clinical endocrinology and metabolism

27 September 2017

published in

1 reference

27 September 2017

volume

10

1 reference

27 September 2017

issue

3

1 reference

27 September 2017

page(s)

371-387

1 reference

GH Secretion in Two Siblings with Laron's Dwarfism: The Effects of Glucose, Arginine, Somatostatin, and Bromocryptine

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Laron dwarfism and mutations of the growth hormone-receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Fractionation studies on plasma of normals and patients with Laron dwarfism and hypopituitary gigantism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

A specific growth hormone-binding protein in human plasma: initial characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Absence of the plasma growth hormone-binding protein in Laron-type dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Circulating levels and molecular distribution of the acid-labile (alpha) subunit of the high molecular weight insulin-like growth factor-binding protein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

A Specific Radioimmunoassay for the Growth Hormone (GH)-Dependent Somatomedin-Binding Protein: Its Use for Diagnosis of GH Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

6 Factors controlling blood concentration of somatomedin C

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

The effect of recombinant human insulin-like growth factor-I treatment on growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Laron's dwarfism: Studies on the nature of the defect

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Imnmnoreactive Properties of the Plasma hGH from Patients with the Syndrome of Familial Dwarfism and High Plasma IR-hGH

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Peripheral Unresponsiveness to Human Growth Hormone in Laron Dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Identification and characterization of specific binding proteins for growth hormone in normal human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Affinity purification and structural characterization of a specific binding protein for human growth hormone in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Receptor-active growth hormone in Laron dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Sequence of cDNA encoding human insulin-like growth factor I precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Administration of Growth Hormone to Patients with Familial Dwarfism with High Plasma Immunoreactive Growth Hormone: Measurement of Sulfation Factor, Metabolic and Linear Growth Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Puberty in Laron type dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

IGF binding protein 3 in patients with Laron type dwarfism: effect of exogenous rIGF-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Growth curves for Laron syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Growth hormone receptor and serum binding protein: purification, cloning and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Spontaneous pregnancies in two women with Laron-type dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Dwarfism with Elevated Levels of Plasma Growth Hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Mouse serum growth hormone (GH) binding protein has GH receptor extracellular and substituted transmembrane domains

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfhydryl group inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Primary somatomedin deficiency: Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron type)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2896%2980500-3

7 January 2021

10.1016/S0950-351X(96)80500-3

Identifiers

DOI

1 reference

27 September 2017

1 reference